Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Brooks

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
European Journal of Pharmacology|February 26, 2000
Activation of multiple mitogen-activated protein kinases by recombinant calcitonin gene-related peptide receptorN Parameswaran, J Disa, W S Spielman, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998
CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activityM Gellai, G F Schreiner, R R Ruffolo, et al.
Pharmacology|July 22, 1998
Angiotensin-converting enzyme inhibition alters clusterin mRNA expression in the kidney following renal mass reductionB A Olson, S M Ali, L C Contino, et al.
The American Journal of Physiology|April 1, 1995
Estradiol attenuates the antidiuretic action of vasopressin in ovariectomized ratsY X Wang, J T Crofton, H Liu, et al.
Endocrinology|July 1, 1986
Central atrial natriuretic factor reduces vasopressin secretion in the ratK Iitake, L Share, J T Crofton, et al.
The American Journal of Physiology|March 1, 1990
Physiological regulation of the renal vasopressin receptor-effector pathway in dogsL B Kinter, N Caldwell, S Caltabiano, et al.
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|January 11, 1991
Drug receptors and control of the cardiovascular system: recent advancesR R Ruffolo, J P Hieble, D P Brooks, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
Comparison of the water diuretic activity of kappa receptor agonists and a vasopressin receptor antagonist in dogsD P Brooks, M Valente, G Petrone, et al.
Proceedings of the Western Pharmacology Society|January 1, 1993
Nonpeptide angiotensin II receptor antagonists: potential advantages over ACE inhibitorsD P Brooks, P D DePalma, T A Fredrickson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 11, 1991
Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058D P Brooks, M P Mitchell, B G Short, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
European Journal of Pharmacology|February 26, 2000
Activation of multiple mitogen-activated protein kinases by recombinant calcitonin gene-related peptide receptorN Parameswaran, J Disa, W S Spielman, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998
CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activityM Gellai, G F Schreiner, R R Ruffolo, et al.
Pharmacology|July 22, 1998
Angiotensin-converting enzyme inhibition alters clusterin mRNA expression in the kidney following renal mass reductionB A Olson, S M Ali, L C Contino, et al.
The American Journal of Physiology|April 1, 1995
Estradiol attenuates the antidiuretic action of vasopressin in ovariectomized ratsY X Wang, J T Crofton, H Liu, et al.
Endocrinology|July 1, 1986
Central atrial natriuretic factor reduces vasopressin secretion in the ratK Iitake, L Share, J T Crofton, et al.
The American Journal of Physiology|March 1, 1990
Physiological regulation of the renal vasopressin receptor-effector pathway in dogsL B Kinter, N Caldwell, S Caltabiano, et al.
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|January 11, 1991
Drug receptors and control of the cardiovascular system: recent advancesR R Ruffolo, J P Hieble, D P Brooks, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
Comparison of the water diuretic activity of kappa receptor agonists and a vasopressin receptor antagonist in dogsD P Brooks, M Valente, G Petrone, et al.
Proceedings of the Western Pharmacology Society|January 1, 1993
Nonpeptide angiotensin II receptor antagonists: potential advantages over ACE inhibitorsD P Brooks, P D DePalma, T A Fredrickson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 11, 1991
Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058D P Brooks, M P Mitchell, B G Short, et al.
Pageof 15